Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemical Recurrence of Malignant Neoplasm of Prostate”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Study completedNCT01431391
What this trial is testing

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmProstate CancerProstatic Adenocarcinoma
Dendreon 68
Large-scale testing (Phase 3)Study completedNCT00089674
What this trial is testing

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Amgen 1,468
Not applicableStudy completedNCT06204302
What this trial is testing

An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Who this might be right for
Non-metastatic Prostate CancerNon-metastatic Castration-resistant Prostate Cancer
Bayer 1,800
Testing effectiveness (Phase 2)Ended earlyNCT00670046
What this trial is testing

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Large-scale testing (Phase 3)UnknownNCT03119857
What this trial is testing

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Who this might be right for
Prostatic Neoplasms
Göteborg University 349
Not applicableNot Yet RecruitingNCT06875297
What this trial is testing

A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 184
Testing effectiveness (Phase 2)Ended earlyNCT03810105
What this trial is testing

Olaparib and Durvalumab in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5
Not applicableStudy completedNCT03927287
What this trial is testing

Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer

Who this might be right for
MetastasisCastration-resistant Prostate CancerDeath
Rabin Medical Center 822
Testing effectiveness (Phase 2)Study completedNCT05526248
What this trial is testing

A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 28
Testing effectiveness (Phase 2)Study completedNCT00499408
What this trial is testing

Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03637543
What this trial is testing

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 31
Early research (Phase 1)Study completedNCT02141659
What this trial is testing

TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

Who this might be right for
Hormone Treatment-naïve Participants With Prostate Cancer
Takeda 43
Testing effectiveness (Phase 2)Ended earlyNCT00814892
What this trial is testing

Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 2
Not applicableLooking for participantsNCT05123391
What this trial is testing

Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmsRadiosurgeryQuality of Life
Pontificia Universidad Catolica de Chile 60
Not applicableUnknownNCT03948204
What this trial is testing

Quality of Life and Shared Decision Making in Prostate Cancer

Who this might be right for
Prostate Cancer
Norwegian Institute of Public Health 10,000
Testing effectiveness (Phase 2)WithdrawnNCT01087580
What this trial is testing

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Who this might be right for
PROSTATE CANCER
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT01341652
What this trial is testing

Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 99
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135
What this trial is testing

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Not applicableStudy completedNCT04400656
What this trial is testing

PROState Pathway Embedded Comparative Trial

Who this might be right for
Prostate CancerNon-metastatic Prostate CancerMetastatic Prostate Cancer+3 more
Imperial College London 139
Load More Results